Lead Exposure in Different Organs of Mammals and Prevention by Curcumin–Nanocurcumin: a Review

Biological Trace Element Research

Volumn 168, Issue 2, 2015, Pages 380-391

  Pal, Mili ^a   Sachdeva, Meenu ^a   Gupta, Niharika ^a   Mishra, Priyanka ^a   Yadav, Mahavir ^a   Tiwari, Archana ^a  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Curcumin; Lead toxicity; Nanocurcumin; Oxidative stress

Indexed keywords

CHITOSAN; CURCUMIN; LEAD; NANOCURCUMIN; NANOPARTICLE; UNCLASSIFIED DRUG; ANTIOXIDANT; CHELATING AGENT; REACTIVE OXYGEN METABOLITE;

ANTIANGIOGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BONE DISEASE; CARDIOVASCULAR DISEASE; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG COATING; DRUG EFFICACY; DRUG RETENTION; DRUG STRUCTURE; ENTRAPMENT EFFICIENCY; ENVIRONMENTAL EXPOSURE; HEART PROTECTION; HEMATOLOGIC DISEASE; HUMAN; HYDROPHOBICITY; LEAD POISONING; LIPID PEROXIDATION; LIVER TOXICITY; LOADING EFFICIENCY; NANOENCAPSULATION; NEPHROTOXICITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; REPRODUCTIVE TOXICITY; SIGNAL TRANSDUCTION; SURFACE AREA; SURFACE CHARGE; SURFACE PROPERTY; TOXICOKINETICS; ANIMAL; BIOAVAILABILITY; BONE; CENTRAL NERVOUS SYSTEM; CHEMISTRY; DRUG EFFECTS; HEART; HEMATOPOIETIC STEM CELL; KIDNEY; LIVER; MAMMAL; METABOLISM; MOUSE; NECROSIS; NERVE CELL; PATHOPHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; BONE AND BONES; CENTRAL NERVOUS SYSTEM; CHELATING AGENTS; CURCUMIN; HEART; HEMATOPOIETIC STEM CELLS; HUMANS; KIDNEY; LEAD; LEAD POISONING; LIVER; MAMMALS; MICE; NANOPARTICLES; NECROSIS; NEURONS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84947022547     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-015-0366-8     Document Type: Article

References (101)

1. Zhang W, Xiong B, Chen L, Lin K, Cui X, Bi H, Guo M, Wang W (2013) Toxicity assessment of Chlorella vulgaris and Chlorella protothecoides following exposure to Pb (II). Environ Toxicol Pharmacol 36(1):51–57
2. Flora G, Gupta D, Tiwari A (2012) Toxicity of lead: a review with recent updates. Interdiscip Toxicol 5(2):47–58
3. Lowry JA (2010) Oral chelation therapy for patients with lead poisoning. Am Acad Pediatr 116:1036–1046
4. Rabinowitz MB, Wetherill G, Kopple JD (1976) Kinetic analysis of lead metabolism in healthy humans. J Clin Investig 58(2):260
5. Bellinger DC, Stiles KM, Needleman HL (1992) Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics 90(6):855–861
6. Research USEPAOo (1977) Air quality criteria for lead
7. Papanikolaou NC, Hatzidaki EG, Belivanis S, Tzanakakis GN, Tsatsakis AM (2005) Lead toxicity update. A brief review. Med Sci Monit 11(10):RA329
8. Zhang J, Cao H, Zhang Y, Zhang Y, Ma J, Wang J, Gao Y, Zhang X, Zhang F, Chu L (2013) Nephroprotective effect of calcium channel blockers against toxicity of lead exposure in mice. Toxicol Lett 218(3):273–280
9. Needleman H (2004) Lead poisoning. Annu Rev Med 55:209–222
10. Bailey C, Kitchen I (1985) Ontogenesis of proenkephalin products in rat striatum and the inhibitory effects of low-level lead exposure. Dev Brain Res 22(1):75–79
11. Shiri R, Ansari M, Ranta M, Falah-Hassani K (2007) Lead poisoning and recurrent abdominal pain. Ind Health 45(3):494–496
12. Jongnarangsin K, Mukherjee S, Bauer MA (1999) An unusual cause of recurrent abdominal pain. Am J Gastroenterol 94(12):3620–3622
13. Ward MS, Henderson AM, Rossi E, Raven JL (1997) Lead poisoning in an electrician: a bad substitute for a bad habit. Med J Aust 166(1):23–24
14. Moriarity RS, Harris JT, Cox RD (2014) Lead toxicity as an etiology for abdominal pain in the emergency department. J Emerg Med 46(2):e35–e38
15. García-Niño WR, Pedraza-Chaverrí J (2014) Protective effect of curcumin against heavy metals-induced liver damage. Food Chem Toxicol 69:182–201
16. Bondy S (1996) Oxygen generation as a basis for neurotoxicity by metals. Toxicology of Metals Chang LW, Eds. CRC Press Boca, Raton pp 699–706
17. Quig D (1998) Cysteine metabolism and metal toxicity. Altern Med Rev 3:262–270
18. Meister A (1988) Glutathione metabolism and its selective modification. J Biol Chem 263(33):17205–17208
19. Hultberg B, Andersson A, Isaksson A (2001) Interaction of metals and thiols in cell damage and glutathione distribution: potentiation of mercury toxicity by dithiothreitol. Toxicology 156(2):93–100
20. Ercal N, Treeratphan P, Hammond TC, Matthews RH, Grannemann NH, Spitz DR (1996) In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso −2, 3-Dimercaptosuccinic acid or N−acetylcysteine. Free Radic Biol Med 21(2):157–161
21. Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344(8924):721–724
22. Hsu P-C, Liu M-Y, Hsu C-C, Chen L-Y, Leon Guo Y (1998) Effects of vitamin E and/or C on reactive oxygen species-related lead toxicity in the rat sperm. Toxicology 128(3):169–179
23. Patra R, Swarup D, Dwivedi S (2001) Antioxidant effects of α tocopherol, ascorbic acid and L-methionine on lead induced oxidative stress to the liver, kidney and brain in rats. Toxicology 162(2):81–88
24. Rubio V, Valverde M, Rojas E (2010) Effects of atmospheric pollutants on the Nrf2 survival pathway. Environ Sci Pollut Res 17(2):369–382
25. Kaspar JW, Niture SK, Jaiswal AK (2009) Nrf2: INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 47(9):1304–1309
26. Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89–116
27. Park JY, Seo YR (2011) The protective role of Nrf2 in cadmium-induced DNA damage. Mol Cell Toxicol 7(1):61–66
28. Kalia K, Flora SJ (2005) Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. J Occup Health 47(1):1–21
29. Woolf DA (1990) Aetiology of acute lead encephalopathy in Omani infants. J Trop Pediatr 36(6):328–330
30. Daniel S, Limson JL, Dairam A, Watkins GM, Daya S (2004) Through metal binding, curcumin protects against lead-and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem 98(2):266–275
31. Sharma R, Street J (1980) Public health aspects of toxic heavy metals in animal feeds. J Am Vet Med Assoc 177(2):149–153
32. Chen J, Chen Y, Liu W, Bai C, Liu X, Liu K, Li R, Zhu J-H, Huang C (2012) Developmental lead acetate exposure induces embryonic toxicity and memory deficit in adult zebrafish. Neurotoxicol Teratol 34(6):581–586
33. Bellinger DC (2013) Prenatal exposures to environmental chemicals and children's neurodevelopment: an update. Saf Health Work 4(1):1
34. Ja L, Gao D, Chen Y, Jing J, Hu Q, Chen Y (2014) Lead exposure at each stage of pregnancy and neurobehavioral development of neonates. Neurotoxicology 44:1–7
35. Bijoor AR, Sudha S, Venkatesh T (2012) Neurochemical and neurobehavioral effects of low lead exposure on the developing brain. Indian J Clin Biochem 27(2):147–151
36. Schnaas L, Rothenberg SJ, Flores M-F, Martinez S, Hernandez C, Osorio E, Velasco SR, Perroni E (2006) Reduced intellectual development in children with prenatal lead exposure. Environ Health Perspect 114:791–797
37. Tobwala S, Wang H-J, Carey JW, Banks WA, Ercal N (2014) Effects of lead and cadmium on brain endothelial cell survival, monolayer permeability, and crucial oxidative stress markers in an in vitro model of the blood–brain barrier. Toxics 2(2):258–275
38. Hermes-Lima M, Pereira B, Bechara E (1991) Are free radicals involved in lead poisoning? Xenobiotica 21(8):1085–1090
39. Casalino E, Calzaretti G, Sblano C, Landriscina C (2002) Molecular inhibitory mechanisms of antioxidant enzymes in rat liver and kidney by cadmium. Toxicology 179(1):37–50
40. Fortune T, Lurie DI (2009) Chronic low‐level lead exposure affects the monoaminergic system in the mouse superior olivary complex. J Comp Neurol 513(5):542–558
41. Zhang R-W, Wei H-P, Xia Y-M, Du J-L (2010) Development of light response and GABAergic excitation-to-inhibition switch in zebrafish retinal ganglion cells. J Physiol 588(14):2557–2569
42. Raouf GAM, Vaibhav K, Khan A, Tabassum R, Ahmed ME, Javed H, Chander K, Islam F, Siddiqui MS (2013) Terminalia arjuna bark extract inhibits histological alterations by mitigating oxidative stress in lead intoxicated mice. Orient Pharm Exp Med 13(4):253–265
43. Chander K, Vaibhav K, Ejaz Ahmed M, Javed H, Tabassum R, Khan A, Kumar M, Katyal A, Islam F, Saeed Siddiqui M (2014) Quercetin mitigates lead acetate-induced behavioral and histological alterations via suppression of oxidative stress, Hsp-70, Bak and upregulation of Bcl-2. Food Chem Toxicol 68:297–306
44. Korashy HM, El-Kadi AO (2012) Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase. Toxicology 291(1):113–121
45. Ademuyiwa O, Agarwal R, Chandra R, Behari JR (2009) Lead-induced phospholipidosis and cholesterogenesis in rat tissues. Chem Biol Interact 179(2):314–320
46. Sipos P, Szentmihályi K, Fehér E, Abaza M, Szilágyi M, Blázovics A (2003) Some effects of lead contamination on liver and gallbladder bile. Acta Biol Szeged 47(1–4):139–142
47. Mahjoub S, Moghaddam AH (2011) The role of exercising and curcumin on the treatment of lead-induced cardiotoxicity in rats. Iran J Health Phys Act 2(1):1–5
48. Patrick L (2006) Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev J Clin Ther 11(2):114–127
49. Rastogi S (2008) Renal effects of environmental and occupational lead exposure. Indian J Occup Environ Med 12(3):103
50. Renner R (2010) Exposure on tap: drinking water as an overlooked source of lead. Environ Health Perspect 118:A68–A74
51. Saleh HA, El-Aziz GA, El-Fark MM, El-Gohary M (2009) Effect of maternal lead exposure on craniofacial ossification in rat fetuses and the role of antioxidant therapy. Anat Histol Embryol 38(5):392–399. doi:10.1111/j.1439-0264.2009.00960.x
52. Prasad S, Gupta SC, Tyagi AK, Aggarwal BB (2014) Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol Adv 32:1053–1064
53. Epstein J, Sanderson IR, MacDonald TT (2010) Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 103(11):1545–1557
54. Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6(1):10
55. Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as “< i> CURECUMIN ”: from kitchen to clinic. Biochem Pharmacol 75(4):787–809
56. Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, Morrow GR (2013) Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 180(1):34–43
57. Vera‐Ramirez L, Pérez‐Lopez P, Varela‐Lopez A, Ramirez‐Tortosa M, Battino M, Quiles JL (2013) Curcumin and liver disease. Biofactors 39(1):88–100
58. Ali T, Shakir F, Morton J (2012) Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication. Digestion 85(4):249–255
59. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang M-T, Fisher C, Flynn E, Byers HR (1998) Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4(6):376
60. Dairam A, Limson JL, Watkins GM, Antunes E, Daya S (2007) Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats. J Agric Food Chem 55(3):1039–1044
61. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM (2004) Phase I clinical trial of oral curcumin biomarkers of systemic activity and compliance. Clin Cancer Res 10(20):6847–6854
62. Tandon S, Singh S, Prasad S, Srivastava S, Siddiqui M (2002) Reversal of lead-induced oxidative stress by chelating agent, antioxidant, or their combination in the rat. Environ Res 90(1):61–66
63. Asali A, Dabidi Roshan DR, Hosseinzadeh H, Soleiman S, Hajizadeh Moghaddam HM (2011) The Role of exercising and curcumin on the treatment of lead-induced cardiotoxicity in rats. Iran J Health Phys Act 2(1):1–5
64. Im K, Maliakel BP (2007) Curcumin: a natural yellow pigment with great potential. Agro FOOD Industry Hi Tech 18(5):52
65. Motohashi H, Yamamoto M (2004) Nrf2–Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10(11):549–557
66. Dinkova-Kostova AT, Talalay P (1999) Relation of structure of curcumin analogs to their potencies as inducers of phase 2 detoxification enzymes. Carcinogenesis 20(5):911–914
67. Flora G, Gupta D, Tiwari A (2013) Preventive efficacy of bulk and nanocurcumin against lead-induced oxidative stress in mice. Biol Trace Elem Res 152(1):31–40
68. Zabihi F, Xin N, Li S, Jia J, Cheng T, Zhao Y (2014) Polymeric coating of fluidizing nano-curcumin via anti-solvent supercritical method for sustained release. J Supercrit Fluids 89:99–105
69. Hassan SK, Mousa AM, Eshak MG, Farrag AERH, Badawi AEFM (2014) Therapeutic and chemopreventive effects of nano curcumin against diethylnitrosamine induced hepatocellular carcinoma in rats. Int J Pharm Pharm Sci 6(3):54
70. Stolnik S, Illum L, Davis S (2012) Long circulating microparticulate drug carriers. Adv Drug Deliv Rev 64:290–301
71. Ravindran J, Prasad S, Aggarwal BB (2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11(3):495–510
72. Rogers NM, Stephenson MD, Kitching A, Horowitz JD, Coates PTH (2012) Amelioration of renal ischaemia–reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen‐presenting cells. Br J Pharmacol 166(1):194–209
73. Basnet P, Hussain H, Tho I, Skalko‐Basnet N (2012) Liposomal delivery system enhances anti‐inflammatory properties of curcumin. J Pharm Sci 101(2):598–609
74. Feng J-Y, Liu Z-Q (2009) Phenolic and enolic hydroxyl groups in curcumin: which plays the major role in scavenging radicals? J Agric Food Chem 57(22):11041–11046
75. Galano A, Álvarez-Diduk R, Ramírez-Silva MT, Alarcón-Ángeles G, Rojas-Hernández A (2009) Role of the reacting free radicals on the antioxidant mechanism of curcumin. Chem Phys 363(1):13–23
76. Sonkaew P, Sane A, Suppakul P (2012) Antioxidant activities of curcumin and ascorbyl dipalmitate nanoparticles and their activities after incorporation into cellulose-based packaging films. J Agric Food Chem 60(21):5388–5399
77. Duan J, Zhang Y, Han S, Chen Y, Li B, Liao M, Chen W, Deng X, Zhao J, Huang B (2010) Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly (butyl cyanoacrylate) nanoparticles. Int J Pharm 400(1):211–220
78. Cole GM, Teter B, Frautschy SA (2007) Neuroprotective effects of curcumin. In: the molecular targets and therapeutic uses of curcumin in health and disease. Springer, pp 197–212
79. Vimala K, Yallapu MM, Varaprasad K, Reddy NN, Ravindra S, Naidu NS, Raju KM (2011) Fabrication of curcumin encapsulated chitosan-PVA silver nanocomposite films for improved antimicrobial activity. J Biomater Nanobiotechnol 2(01):55
80. Lundvig DM, Immenschuh S, Wagener FA (2012) Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly? The role of bile pigments in health and disease: effects on cell signaling, cytotoxicity and cytoprotection 64
81. Ghiassi-Nejad Z, Friedman SL (2008) Advances in antifibrotic therapy
82. Lin YL, Lin CY, Chi CW, Huang YT (2009) Study on antifibrotic effects of curcumin in rat hepatic stellate cells. Phytother Res 23(7):927–932
83. Punithavathi D, Venkatesan N, Babu M (2000) Curcumin inhibition of bleomycin‐induced pulmonary fibrosis in rats. Br J Pharmacol 131(2):169–172
84. Shu J-C, He Y-J, Lv X, Ye G-R, Wang L-X (2009) Curcumin prevents liver fibrosis by inducing apoptosis and suppressing activation of hepatic stellate cells. J Nat Med 63(4):415–420
85. Tsai Y-M, Chien C-F, Lin L-C, Tsai T-H (2011) Curcumin and its nano-formulation: the kinetics of tissue distribution and blood–brain barrier penetration. Int J Pharm 416(1):331–338
86. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A (2007) Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnol 5(3):1–18
87. Muller RH, Keck CM (2004) Challenges and solutions for the delivery of biotech drugs—a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113(1):151–170
88. Mukerjee A, Vishwanatha JK (2009) Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 29(10):3867–3875
89. Faisant N, Siepmann J, Benoit J (2002) PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur J Pharm Sci 15(4):355–366
90. Zolnik BS, Burgess DJ (2007) Effect of acidic pH on PLGA microsphere degradation and release. J Control Release 122(3):338–344
91. Mittal G, Sahana D, Bhardwaj V, Kumar MR (2007) Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release 119(1):77–85
92. Shaikh J, Ankola D, Beniwal V, Singh D, Kumar MR (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37(3):223–230
93. De Villiers MM, Aramwit P, Kwon GS (2008) Nanotechnology in drug delivery. Springer Science & Business Media
94. Prokop A, Kozlov E, Carlesso G, Davidson JM (2002) Hydrogel-based colloidal polymeric system for protein and drug delivery: physical and chemical characterization, permeability control and applications. In: Filled Elastomers Drug Delivery Systems. Springer, pp 119–173
95. Yallapu MM, Jaggi M, Chauhan SC (2013) Curcumin nanomedicine: a road to cancer therapeutics. Curr Pharm Des 19(11):1994
96. Flora G, Gupta D, Tiwari A (2013) Nanocurcumin: a promising therapeutic advancement over native curcumin. Crit Rev Ther Drug Carrier Syst 30(4):331–368
97. Das M, Sahoo SK (2012) Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance. PLoS One 7(3):e32920
98. Ganta S, Amiji M (2009) Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm 6(3):928–939
99. Misra R, Sahoo SK (2011) Coformulation of doxorubicin and curcumin in poly (D, L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm 8(3):852–866
100. Cheng KK, Yeung CF, Ho SW, Chow SF, Chow AH, Baum L (2013) Highly stabilized curcumin nanoparticles tested in an in vitro blood–brain barrier model and in Alzheimer’s disease Tg2576 mice. AAPS J 15(2):324–336
101. Basniwal RK, Khosla R, Jain N (2014) Improving the anticancer activity of curcumin using nanocurcumin dispersion in water. Nutr Cancer 66(6):1015–1022